Professor of Medicine;
Rosalyn R. Shostak Heyman and Hannah Kully Shostak Endowed Chair;
Professor of Surgery;
Professor of Molecular and Medical Pharmacology;
Director
Parker Institute for Cancer Immunotherapy
University of California, Los Angeles
Los Angeles, CA
For exceptional leadership and extraordinary achievements in cancer research, including pioneering contributions to melanoma biology and cancer immunotherapy that have been instrumental in the clinical development of pembrolizumab and other transformative therapies. His seminal research has accelerated progress in cancer treatment by defining mechanisms of response and resistance to immunotherapy and guiding the rational design of innovative combination therapy approaches. Through his sustained leadership in clinical and translational research and service to the cancer research community, Dr. Ribas has played a pivotal role in advancing modern cancer medicine and has made a profound impact on patients and the broader cancer research field.
The AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research was established in 2007 to recognize a champion of cancer research whose leadership and extraordinary achievements in cancer research have had a major impact on the field. Such achievements may include scientific contributions to the acceleration of progress against cancer, significant accomplishments associated with national or international awareness of the importance of cancer research, or other ways of demonstrating a sustained extraordinary commitment to cancer research. To learn more please visit the press release.
View Dr. Ribas’ Fellow of AACR Academy page.
View Past Recipients.